David C Fajgenbaum

University Of Pennsylvania

$7,024,320

Attributed

$7,024,320

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,434,739 · 1

FDA$1,589,581 · 1

By mechanism

R01$7,024,320 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Yan Yuan$11,534,388
Leslie M Shaw$12,501,706
Andrei Thomas-Tikhonenko$8,144,872
Michael R King$8,012,934
Philip Richard Gehrman$7,084,520

Others in their field

Other Emerging Leaders on “In Vitro”

Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
Tony Moody · Duke University$34,777,314

Research focus

In VitroLymph NodesIn Complete RemissionInterruptionIn VivoHematologyHuman Herpesvirus 8HypersensitivityInflammatory MarkerInterleukin-6CytokineBody SystemCytotoxic ChemotherapyCell TypeFunctional DisorderDiagnosisDisease ProgressionDisease RemissionInflammatoryEtiologyFda ApprovedFlareFrap1 GeneMediating